Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
A-fib; This is a spontaneous report received from a Consumer or other non HCP. A 62-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "A-fib". The patient was reported to have experienced palpitations, A-fib, chest pain, and shortness of breath after receiving 2nd Pfizer vaccine. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.